AFib is a leading cause of stroke in the U.S., but often does not present symptoms until a stroke or other serious cardiovascular event occurs. In the study, participants will use the iPhone Heartline Study app and the Apple Watch’s ECG app and irregular heart rhythm notifications to speed and improve AFib detection, allowing for earlier interventions in patients with a high risk of stroke, therefore potentially reducing the likelihood of stroke.
To participate in the two-year study, patients must be at least 65 years old, have Original Medicare, own an iPhone and agree to give researchers access to their Medicare claims data. Not all participants will be required to use an Apple Watch for the study; those that are will have the option to purchase one or borrow one for the duration of the study.
Beyond tracking their heart health, the Heartline Study app will also regularly provide participants with education, tips and questionnaires to help improve their overall health and wellness.
“Apple technology is making a meaningful impact on scientific research through the powerful capabilities of iPhone and Apple Watch, all with privacy at the center of the participant experience,” Myoung Cha, Apple’s head of health strategic initiatives, said in a news release. “The Heartline Study will help further understanding of how our technology could both contribute to science and help improve health outcomes, including reducing the risk of stroke.”
More articles on health IT:
Amazon most mentioned among emerging health IT companies, KLAS finds
5 technologies predicted to change healthcare over next 10 years
Google makes cuts to cloud team: 5 things to know about its strategy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
